510(k) K242170
K242170 is an FDA 510(k) premarket notification submitted by Kamiya Biomedical Company, LLC for the device "K-ASSAY CRP (Ver.2)". The FDA issued a decision of Substantially Equivalent on April 18, 2025. The device falls under product code DCK (C-Reactive Protein, Antigen, Antiserum, And Control), a Class II device regulated under 21 CFR 866.5270.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- April 18, 2025
- Date Received
- July 24, 2024
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- C-Reactive Protein, Antigen, Antiserum, And Control
- Device Class
- Class II
- Regulation Number
- 866.5270
- Review Panel
- IM
- Submission Type